- Prognostic Role of Circulating Tumor Cells in the Pulmonary Vein, Peripheral Blood, and Bone Marrow in Resectable NonSmall Cell Lung Cancer
-
Lee JM, Jung W, Yum S, Lee JH, Cho S
- KMID: 2530404
- J Chest Surg.
- 2022 Jun;55(3):214-224.
- doi: 10.5090/jcs.21.140
Background: Studies of the prognostic role of circulating tumor cells (CTCs) in early-stage non-small cell lung cancer (NSCLC) are still limited. This study investigated the prognostic power of CTCs from... -
- CITED
-
- Close
- SHARE
-
- Close
- Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non-Small Cell Lung Cancer
-
Shin HS, Choi J, Lee J, Lee SY
- KMID: 2528215
- Cancer Res Treat.
- 2022 Apr;54(2):458-468.
- doi: 10.4143/crt.2021.425
Purpose Histone deacetylase inhibitors (HDACis) are epigenetic regulators and used clinically for hematopoietic malignancies. Recently, HDACis have received attention as a factor that modulates the immune system. In this study,... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Impact of Postoperative Complications in High-Risk Operable Non-small Cell Lung Cancer
-
Lee S, Roknuggaman M, Son JA, Hyun S, Jung J, Haam S, Yu WS
- KMID: 2525267
- J Chest Surg.
- 2022 Feb;55(1):20-29.
- doi: 10.5090/jcs.21.100
Background: Patients with high-risk (HR) operable non-small cell lung cancer (NSCLC) may have unique prognostic factors. This study aimed to evaluate surgical outcomes in HR patients and to investigate prognostic... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Survival in Non–Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment
-
Kim H, Park S, Jung HA, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ
- KMID: 2524596
- Cancer Res Treat.
- 2022 Jan;54(1):150-156.
- doi: 10.4143/crt.2021.306
Purpose Metachronous brain-only oligorecurrence in patients with non–small cell lung cancer (NSCLC) is a rare event with favorable prognosis, but the clinical outcome has not been fully determined. We retrospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Impact of Capmatinib in the Treatment of Advanced Non–Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification
-
Choi W, Park SY, Lee Y, Lim KY, Park M, Lee GK, Han JY
- KMID: 2521578
- Cancer Res Treat.
- 2021 Oct;53(4):1024-1032.
- doi: 10.4143/crt.2020.1331
Purpose Capmatinib, an oral MET kinase inhibitor, has demonstrated its efficacy against non–small cell lung cancer (NSCLC) with MET dysregulation. We investigated its clinical impact in advanced NSCLC with MET... -
- CITED
-
- Close
- SHARE
-
- Close
- Current advances in the treatment of lung cancer with immune checkpoint inhibitors
-
Lee GW
- KMID: 2515932
- J Korean Med Assoc.
- 2021 May;64(5):333-341.
- doi: 10.5124/jkma.2021.64.5.333
Lung cancer is the leading cause of cancer-related deaths worldwide despite major advances in platinum-based chemotherapy and targeted therapy based on activating driving mutations. Immune checkpoint inhibitors (ICIs) have revolutionized... -
- CITED
-
- Close
- SHARE
-
- Close
- Delphinidin enhances radio-therapeutic effects via autophagyinduction and JNK/MAPK pathway activation in non-small celllung cancer
-
Kang SH, Bak DH, Chung BY, Bai HW, Kang BS
- KMID: 2505776
- Korean J Physiol Pharmacol.
- 2020 Sep;24(5):413-422.
- doi: 10.4196/kjpp.2020.24.5.413
Delphinidin is a major anthocyanidin compound found in various vegetablesand fruits. It has anti-oxidant, anti-inflammatory, and various other biologicalactivities. In this study we demonstrated the anti-cancer activity of delphinidin,which was... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Primary Tumor Resection in Patients with Pleural Metastasis Encountered at the Time of Surgery
-
Park S, Chung Y, Lee HJ, Park IK, Kang CH, Kim YT
- KMID: 2502545
- Korean J Thorac Cardiovasc Surg.
- 2020 Jun;53(3):114-120.
- doi: 10.5090/kjtcs.2020.53.3.114
Background: Evidence is lacking on whether the resection of lung parenchymal cancer improves the survival of patients with unexpected pleural metastasis encountered during surgery. We conducted a single-center retrospective study... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Affecting the Number of Stapler Cartridges in Complete Video-Assisted Thoracoscopic Surgery Lobectomy for Non-small Cell Lung Cancer
-
Yang YH, Lee e, Lee CY, Kim DJ, Lee JG, Chung KY
- KMID: 2502534
- Korean J Thorac Cardiovasc Surg.
- 2020 Apr;53(2):53-57.
- doi: 10.5090/kjtcs.2020.53.2.53
Background: Video-assisted thoracoscopic surgery (VATS) lobectomy has become the major surgical option for the treatment of non-small cell lung cancer (NSCLC). Endoscopic instruments such as stapler cartridges are essential for... -
- CITED
-
- Close
- SHARE
-
- Close
- Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
-
Ahn MJ, Han JY, Kim DW, Cho BC, Kang JH, Kim SW, Yang JCH, Mitsudomi , Lee JS
- KMID: 2501220
- Cancer Res Treat.
- 2020 Jan;52(1):284-291.
- doi: 10.4143/crt.2019.200
Purpose Osimertinib is a third-generation, irreversible, oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that potently and selectively inhibits both EGFR sensitizing mutation and EGFR T790M and has demonstrated... -
- CITED
-
- Close
- SHARE
-
- Close
- SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer
-
Kwak YK, Park HH, Choi KH, Park EY, Sung SY, Lee SW, Hong JH, Lee HC, Yoo IR, Kim YS
- KMID: 2501204
- Cancer Res Treat.
- 2020 Jan;52(1):85-97.
- doi: 10.4143/crt.2019.007
Purpose Fluorodeoxyglucose positron emission tomography–computed tomography (PET-CT) is gaining evidence as a predictive factor in non-small cell lung cancer (NSCLC). Stereotactic ablative radiotherapy (SABR) is the standard treatment in early-stage NSCLC... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Pleural Attachment and Indentation of Subsolid Nodule Lung Cancer
-
Kim HJ, Cho JY, Lee YJ, Park JS, Cho YJ, Yoon HI, Chung JH, Cho S, Kim K, Lee KW, Lee JH, Lee CT
- KMID: 2460602
- Cancer Res Treat.
- 2019 Oct;51(4):1540-1548.
- doi: 10.4143/crt.2019.057
PURPOSE: Lung cancers presenting as subsolid nodule commonly have peripheral location, making the cancer-pleura relationship noteworthy. We aimed to evaluate the effect of pleural attachment and/or indentation on visceral pleural... -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative Risk Factors for Pathologic N2 Metastasis in Positron Emission Tomography-Computed Tomography–Diagnosed N0–1 Non-Small Cell Lung Cancer
-
Yoon TH, Lee CH, Park KS, Bae CH, Cho JW, Jang JS
- KMID: 2455147
- Korean J Thorac Cardiovasc Surg.
- 2019 Aug;52(4):221-226.
- doi: 10.5090/kjtcs.2019.52.4.221
BACKGROUND: Accurate mediastinal lymph node staging is vital for the optimal therapy and prognostication of patients with lung cancer. This study aimed to determine the preoperative risk factors for pN2... -
- CITED
-
- Close
- SHARE
-
- Close
- A Meta-Analysis Comparing Lobectomy versus Segmentectomy in Stage I Non-Small Cell Lung Cancer
-
Lim TY, Park S, Kang CH
- KMID: 2455145
- Korean J Thorac Cardiovasc Surg.
- 2019 Aug;52(4):195-204.
- doi: 10.5090/kjtcs.2019.52.4.195
Lobectomy is considered the standard strategy for early-stage non-small cell lung cancer (NSCLC). However, sublobar resection for NSCLC has recently received increased attention. The objective of this study was to... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors in Stage IIB Non-Small Cell Lung Cancer according to the 8th Edition of TNM Staging System
-
Shin JW, Cho DG, Choi SY, Park JK, Lee KY, Moon Y
- KMID: 2455156
- Korean J Thorac Cardiovasc Surg.
- 2019 Jun;52(3):131-140.
- doi: 10.5090/kjtcs.2019.52.3.131
BACKGROUND: The purposes of this study were to evaluate the appropriateness of the stage migration of stage IIA non-small cell lung cancer (NSCLC) in the seventh edition of the tumor,... -
- CITED
-
- Close
- SHARE
-
- Close
- The Risk of Herpes Zoster in Patients with Non-small Cell Lung Cancer according to Chemotherapy Regimens: Tyrosine Kinase Inhibitors versus Cytotoxic Chemotherapy
-
Choi JY, Kim M, Keam B, Kim TM, Kim DW, Heo DS, Jo SJ
- KMID: 2437610
- Cancer Res Treat.
- 2019 Jan;51(1):169-177.
- doi: 10.4143/crt.2017.491
PURPOSE: Despite the successful use of tyrosine kinase inhibitors (TKIs) in cancer patients, their effect on herpes zoster development has not been studied. The aim of this study was to... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
-
Kim TM, Lee KW, Oh DY, Lee JS, Im SA, Kim DW, Han SW, Kim YJ, Kim TY, Kim JH, Han H, Kim WH, Bang YJ
- KMID: 2417872
- Cancer Res Treat.
- 2018 Jul;50(3):835-842.
- doi: 10.4143/crt.2017.303
PURPOSE: Poziotinib, a pan-human epidermal growth factor receptor 2 (HER) tyrosine kinase inhibitor, has shown potent activity againstwild type of epidermal growth factorreceptor(EGFR) family kinases including EGFR, HER2, and HER4... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Implications of Postoperative Infectious Complications in Non-Small Cell Lung Cancer
-
Jang HJ, Song JW, Cho S, Kim K, Jheon S
- KMID: 2409712
- Korean J Thorac Cardiovasc Surg.
- 2018 Feb;51(1):41-52.
- doi: 10.5090/kjtcs.2018.51.1.41
BACKGROUND: Few studies have evaluated the long-term impact of postoperative infectious complications in patients with non-small cell lung cancer (NSCLC). We aimed to determine the impact of infectious complications on... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of Pulmonary Resection and Mediastinal Node Dissection by Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoradiation Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer
-
Jeon YJ, Choi YS, Lee KJ, Lee SH, Pyo H, Choi JY
- KMID: 2409710
- Korean J Thorac Cardiovasc Surg.
- 2018 Feb;51(1):29-34.
- doi: 10.5090/kjtcs.2018.51.1.29
BACKGROUND: We evaluated the feasibility and outcomes of pulmonary resection and mediastinal node dissection (MND) by video-assisted thoracoscopic surgery (VATS) following neoadjuvant therapy for stage IIIA N2 non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
-
Lee Y, Lee KH, Lee GK, Lee SH, Lim KY, Joo J, Go YJ, Lee JS, Han JY
- KMID: 2394819
- Cancer Res Treat.
- 2017 Oct;49(4):1001-1011.
- doi: 10.4143/crt.2016.546
PURPOSE: This phase II study examined whether the addition of simvastatin to afatinib provides a clinical benefit compared with afatinib monotherapy in previously treated patients with nonadenocarcinomatous non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
